Market Recap — March 27, 2026
Recap of insider activity, SEC filings, and market-moving news for March 27, 2026.
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Origin Materials Reports Substantial Doubt About Going Concern, Massive Losses, and Failed Financing Amid Restructuring
Galaxy Gaming Reports Profitability, Digital Growth, and Provides Update on Pending $3.20/Share Merger
Femto Technologies to Acquire 40% Stake in AI Software Company Gilad for $1.35M, a Transformational Bet for the Micro-Cap Firm
Pulmatrix to Merge with Eos SENOLYTIX in Highly Dilutive Reverse Merger; Existing Shareholders to Own 6% of Combined Entity
KBS REIT III Issues Going Concern Warning Amidst $1.3B Debt Maturities and Significant Asset Impairments
HiTek Global Prices $3M Direct Offering, Shares Face Extreme Dilution
Selling Stockholders Register Resale of 8 Million Shares from Warrants, Potentially Doubling Outstanding Stock Amidst Financial Distress
FG Nexus Files $5.0 Billion Universal Shelf Registration, Including $2.5 Billion ATM, Amidst Financial Distress
Iterum Therapeutics Files for Winding Up in Ireland, Appoints Liquidators, CEO/CFO Resign
Braskem Reports Steep 2025 Net Loss, Soaring Leverage, and Subsidiary Bond Defaults Amid Industry Downturn
Braskem Reports Massive Net Loss, Sky-High Leverage, and Subsidiary Default Amid Deep Downcycle
Shell Company NON INVASIVE MONITORING SYSTEMS INC Announces Transformational Merger with Gravitics, Plans Nasdaq Uplisting and $40M Offering
No high-importance items captured for this date.
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
CEO Ho Kin Wai Makes Significant $958K Open Market Purchase in Primech Holdings
Director Nicholas Varischetti Buys Nearly $1 Million in FMNB Stock
Executive Chairman increases stake with over $339K in open market purchases
10% Owner Eric L. Oliver's SoftVest Buys $284K in CRT Shares
Medifast CEO Daniel Chard Buys $178K in Stock Amidst Activist Agreement
CEO and Executive Chairman Make Significant Open Market Stock Purchases
Director Buys $98K in Lument Finance Trust Preferred Stock Near 52-Week Lows
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
Executive Chairman Sells $2.74M in Shares Following Recent Form 144 Filing
Protagonist Therapeutics CFO Sells $2.58M in Stock
CEO Sells Over $152K in Shares Following Negative 10-K and Shelf Offering Filing
President & CFO Sells $73K in Open Market Shares
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Pulmatrix to Merge with Eos SENOLYTIX in Highly Dilutive Reverse Merger; Existing Shareholders to Own 6% of Combined Entity
HiTek Global Prices $3M Direct Offering, Shares Face Extreme Dilution
Iterum Therapeutics Files for Winding Up in Ireland, Appoints Liquidators, CEO/CFO Resign
Hydrofarm Defaults on Term Loan, Reports $242M Q4 Loss, Explores Strategic Alternatives
Hydrofarm Holdings Reports Staggering $51.89 Per Share Q4 Loss, Signaling Severe Financial Distress
Judge Orders Nexstar to Hold Tegna Assets Separate Amid Antitrust Lawsuit
Dyadic International Receives Second Nasdaq Delisting Notice, Citing Financial Metrics Deficiency
Presidio Property Trust Reports Deepening Losses, Property Receivership, and Significant Impairments for 2025
Enveric Biosciences Reports $8.77M Annual Loss, Pre-Revenue Status Confirmed in 10-K
Enveric Biosciences Reports Positive Preclinical Data and Major IP Win Amidst Ongoing Capital Raises
No notable 8-Ks or news items on this date.
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Affiliate Files Intent to Sell $13.3M in Shares, Continuing Recent Pattern
Officer John Holmes Files Intent to Sell $2.8M in Shares Following Option Exercise
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.